Notably, the effectiveness of MALAT1-ASO treatment in inhibiting the survival and proliferation of NRAS- and BRAF-mutated melanoma cells is surprising in light of MALAT1 being strongly downregulated in patient samples of melanoma. The gene discussed is NRAS; the disease is melanoma.